FDA approves Boston Scientific's newest deep brain stimulator for Parkinson's disease
Jan 25, 2021 7:30am The fourth generation of Boston Scientific's Vercise Genus system was approved for the stimulation of areas of the brain linked to the control of behavior and movement for patients with Parkinson’s disease who have responded to levodopa treatment, but whose symptoms are not adequately controlled with medication alone. (Boston Scientific) Boston Scientific has obtained approval from the FDA for the fourth generation of its Vercise Genus deep brain stimulation system, allowing conditional use while within an MRI scanner. Designed to treat the symptoms of Parkinson...
Source: fiercebiotech.com
